Emi Sakurai, Masahiro Kamata, Hideaki Uchida, Yoshiki Okada, Shoya Suzuki, Ryosuke Takeshima, Makoto Ito, Ayu Watanabe, Itsumi Mizukawa, Shota Egawa, Chika Chijiwa, Azusa Hiura, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Atopic dermatitis (AD) places a burden on work productivity. Recently, dupilumab was approved for AD, but its impact on work productivity in Japanese patients has not been reported. Furthermore, data on the effect of long-term treatment with dupilumab on work productivity are limited. We investigated the work productivity and activity in Japanese patients with moderate-to-severe AD, utilizing the Japanese version of the Work Productivity and Activity Impairment (WPAI-AD-Japan) questionnaire. Furthermore, we examined the impact of dupilumab on work productivity...
February 2024: Experimental Dermatology